NIA Small Business Funding Opportunities
Potential applicants are strongly encouraged to read the NIH-NIA SBIR-STTR information and guidance on the NIH SBIR-STTR website.
All potential applicants are strongly encouraged to contact NIA's SBIR-STTR Program Coordinator to determine if their potential SBIR-STTR research and development would be appropriate for NIA.
NIH SBIR-STTR Funding Opportunity Announcements:
NIA SBIR-STTR FOAs targeting Alzheimer's disease (AD) and AD-related dementias (ADRD) and Translational Research:
- 2019 NIH SBIR Omnibus Solicitation — Clinical Trial Not Allowed
- 2019 NIH SBIR Omnibus Solicitation — Clinical Trial Required
- 2019 NIH STTR Omnibus Solicitation — Clinical Trial Not Allowed
- 2019 NIH STTR Omnibus Solicitation — Clinical Trial Required
- 2019 NIA SBIR-STTR Research Topics and Budget Limits (PDF, 2.3M)
- 2019 NIH SBIR-STTR Omnibus SBA-Approved-Waiver Research Topics (PDF, 554K)
NIA SBIR-STTR FOAs targeting Alzheimer's disease (AD) and AD-related dementias (ADRD) and Translational Research:
- Alzheimer's Disease (AD) and AD-related dementias (ADRD):
- Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44)
- Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42)
- Tools for Clinical Care and Management of Alzheimer's Disease (AD) and its Commorbidities (R43/R44)
- Tools for Clinical Care and Management of Alzheimer's Disease (AD) and Its Commorbidities (R41/R42)
- Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44)
- Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42)
- Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer's Disease (AD/ADRD) (SBIR R43/R44 Clinical Trial Not Allowed)
- Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer's Disease (AD/ADRD) (STTR R41/R42) Clinical Trials Not Allowed)
- Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (SBIR R43/R44 Clinical Trial Not Allowed)
- Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (STTR R41/R42 Clinical Trial Not Allowed)
- Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 Clinical Trial Optional)
- Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 Clinical Trial Optional)
- Translational Research on Aging:
- T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44)
- T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44)
- Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)
- Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R41/R42 Clinical Trial Not Allowed)
Return to the NIA Small Business Main Page.